Kim Cham-Mill, Zhao Victor, Brito De Mello Maeve, Baggaley Rachel, Johnson Cheryl C, Spielman Erica, Fairley Christopher K, Zhang Lei, de Vries Henry, Klausner Jeffrey, Zhao Rui, Ong Jason J
Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland.
Int J Infect Dis. 2023 Apr;129:181-187. doi: 10.1016/j.ijid.2023.01.007. Epub 2023 Jan 20.
Although the World Health Organization recommends 'frequent' screening of sexually transmitted infections (STI) for people who use pre-exposure prophylaxis for HIV, there is no evidence for optimal frequency.
We searched five databases and used random-effects meta-analysis to calculate pooled estimates of STI test positivity. We narratively synthesized data on secondary outcomes, including adherence to recommended STI screening frequency and changes in STI epidemiology.
Of 7477 studies, we included 38 for the meta-analysis and 11 for secondary outcomes. With 2-3 monthly STI screening, the pooled positivity was 0.20 (95% confidence interval [CI]: 0.15-0.25) for chlamydia, 0.17 (95% CI: 0.12-0.22) for gonorrhea, and 0.07 (95% CI: 0.05-0.08) for syphilis. For chlamydia and gonorrhea, the positivity was approximately 50% and 75% lower, respectively, in studies that screened 4-6 monthly vs 2-3 monthly. There was no significant difference in the positivity for syphilis in studies that screened 4-6 monthly compared to 2-3 monthly. Adherence of clients to recommended screening frequency varied significantly (39-94%) depending on population and country. Modeling studies suggest more frequent STI screening could reduce incidence.
Although more frequent STI screening could reduce delayed diagnoses and incidence, there remain significant knowledge gaps regarding the optimal STI screening frequency.
尽管世界卫生组织建议对采用暴露前预防措施预防艾滋病毒的人群“定期”筛查性传播感染(STI),但尚无证据表明最佳筛查频率。
我们检索了五个数据库,并使用随机效应荟萃分析来计算性传播感染检测阳性率的合并估计值。我们对次要结果的数据进行了叙述性综合分析,包括对推荐的性传播感染筛查频率的依从性以及性传播感染流行病学的变化。
在7477项研究中,我们纳入了38项进行荟萃分析,11项用于次要结果分析。对于衣原体感染,每月进行2 - 3次性传播感染筛查时,合并阳性率为0.20(95%置信区间[CI]:0.15 - 0.25);淋病为0.17(95% CI:0.12 - 0.22);梅毒为0.07(95% CI:0.05 - 0.08)。对于衣原体感染和淋病,与每月进行2 - 3次筛查的研究相比,每月进行4 - 6次筛查的研究中,阳性率分别降低了约50%和75%。每月进行4 - 6次筛查的研究与每月进行2 - 3次筛查的研究相比,梅毒的阳性率没有显著差异。根据人群和国家的不同,客户对推荐筛查频率的依从性差异很大(39% - 94%)。模型研究表明,更频繁的性传播感染筛查可能会降低发病率。
尽管更频繁的性传播感染筛查可以减少延迟诊断和发病率,但关于最佳性传播感染筛查频率仍存在重大知识空白。